Lifeaz, a Paris-based startup specialising in the democratisation of defibrillators for individuals and businesses, today announced that it has raised €13 million in funding to accelerate its growth and prepare its European rollout.
Existing investor Mutuelles Impact (a fund initiated by La Mutualité Française and managed by XAnge in partnership with Impactivist, formerly called Investir&+) supported this round, with participation from new leading investors, including BNP Paribas, GO CAPITAL and Mirova (an affiliate of Natixis).
Johann Kalchman, co-founder and CEO of Lifeaz, said, “Over the past ten years, Lifeaz has continuously demonstrated the need to democratize access to defibrillators. Our vision is that tomorrow, wherever you are, there will be a defibrillator less than one minute away and people who feel confident to step in and save a life – whether at home, in a restaurant, a hotel, a gym, a medical practice or at work.
“This fundraising, therefore, marks a major milestone: the renewed trust of our historical investors and the arrival of new leading partners now give us the means to scale. After more than 100 lives saved, our ambition is clear: to multiply our impact by saving 1,000 lives within five years, in France and across Europe.”
During 2025-2026, EU-Startups has covered several hardware and software-based cardiovascular HealthTech funding rounds. Most recently, in Jaunary 2026, Bordeaux and Tours-based FineHeart, a clinical-stage medical device company developing technologies in the cardiovascular space, announced the completion of a €35 million first closing of its Series C financing round. In July 2025, Oxford-based Ultromics, an innovator in AI-driven cardiology diagnostics solutions, announced it had raised €48 million through its Series C funding round. In June 2025, Bordeaux-based DESKi closed a €5.2 million Seed round to support the U.S. and global market launch of its FDA-approved cardiac imaging software, HeartFocus. Again in June 2025, Helsinki-based AIATELLA secured €2 million in funding to scale its AI-powered cardiovascular imaging technology and prevent 100 million strokes
Founded in 2015 by Johann Kalchman, Martial Itty, Timothée Soubise, and Jonathan Levy-Bencheton, Lifeaz’s mission is to enable all citizens to save lives in the event of cardiac arrest. To achieve this, the startup developed the first defibrillator designed for home use and later introduced a version for businesses. Its defibrillator is called Clark and is designed in Paris and manufactured in Honfleur, Normandy.
By offering an easy-to-use defibrillator equipped with connected technology enabling remote monitoring and maintenance through daily technical self-tests, Lifeaz ensures that the device is fully operational in case of emergency. It also offers training programmes, delivered via an app, video sessions and in-person training, that enable everyone to learn life-saving actions and feel confident to act in an emergency. Together, these measures enable Lifeaz to make sure it democratises access to defibrillators.
The company offers these solutions through a business model, a turnkey rental solution combining the defibrillator, connected maintenance, consumables replacement and training.
With this fresh capital, Lifeaz aims to increase the number of lives saved from 100 to 1,000, grow from 25,000 to over 100,000 customers, initiate European expansion, and strengthen its teams with around 20 new hires starting in 2026.
Read the orginal article: https://www.eu-startups.com/2026/02/paris-based-lifeaz-raises-e13-million-to-democratise-defibrillator-access-and-save-1000-lives-within-five-years/
